Science and engineering
29.08.2017, 15:33
A team of scientists appear to have detected the first X-rays coming from a type Ia supernova.
29.08.2017, 14:24
When musician Dan Fabbio had a tumor in an area of his brain responsible for music function, treatment involved playing the saxophone during surgery.
29.08.2017, 13:37
New research calculates the benefits of replacing synthetic fertilizers with the original—manure.
29.08.2017, 09:19
Celyad’s management will host a conference call at 2pm CEST / 8am EDT today
28.08.2017, 10:54
Sanofi announced today that it has completed the acquisition of Protein Sciences, a vaccines biotechnology company based in Meriden, Connecticut in the United States
28.08.2017, 08:59
Kuros receives clearance for MagnetOs Putty for commercialization in the United States and files the product for CE marking in Europe
25.08.2017, 17:30
The advent of farming—particularly dairy farming—may have changed the shape of the human skull.
25.08.2017, 17:29
People who get less REM sleep, or take a long time to reach REM sleep, may have a higher risk of developing dementia.
25.08.2017, 17:27
Last flu season, vaccination rates for kids may have fallen because the CDC warned parents away from nasal spray versions.
24.08.2017, 17:18
"Anti-sense" RNA guides the stripping of myelin from injured nerves, report researchers. The finding could lead to treatments for nerve damage.
24.08.2017, 17:15
New mapping methods developed by researchers at the Department of Energy’s Oak Ridge National Laboratory can help urban planners minimize the environmental impacts of cities’ water and energy demands on surrounding stream ecologies.
24.08.2017, 16:51
A new algorithm can predict the beginning of Alzheimer's disease years in advance, which would give patients and families time to plan and manage care.
24.08.2017, 16:50
A prosthetic device that includes augmented reality goggles could eventually restore vision lost to retinitis pigmentosa or macular degeneration.
24.08.2017, 15:26
Novartis Kisqali® (ribociclib) receives EU approval as first-line treatment for HR+/HER2- locally advanced or metastatic breast cancer in combination with any aromatase inhibitor
Комментарии